Amgen wins European approval for Uplizna in generalised myasthenia gravis

Arctic Therapeutics enrols first patients in Phase IIa trial of AT-004 for acne vulgaris

BillionToOne launches two new add-on liquid biopsy applications for Northstar Select

Iterion Therapeutics reports first patient dosed in clinical study of tegavivint

FDA accepts Takeda's oveporexton NDA with priority review for narcolepsy type 1

Innocan Pharma reports findings from clinical study of LPT-CBD in dogs

Lunai Bioworks starts new oncology collaboration with clinical-stage partner

Median Technologies secures FDA clearance for AI lung cancer screening software

Sanofi's rilzabrutinib receives FDA breakthrough and Japan orphan designations for rare anaemia

Ascentage Pharma receives China IND clearance for BTK degrader APG‑3288

Partner Therapeutics' zenocutuzumab-zbco granted US FDA Orphan Drug Designation for treatment of cholangiocarcinoma

FDA issues EUA for Boehringer Ingelheim's IVOMEC (ivermectin) 1% Injection

Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban

Hologic receives FDA approval for Aptima HPV assay as primary screening option

AbbVie submits FDA and EMA applications for new upadacitinib indication in NSV